Galapagos NV GLPG-NL:Euronext Amsterdam

*Data is delayed | EUR
Last | 3:29 PM CEST
62.36quote price arrow up+1.38 (+2.26%)
Volume
279,156
52 week range
57.86 - 216.10

...

Loading . . .
  • Open61.37
  • Day High62.89
  • Day Low61.10
  • Prev Close60.98
  • 52 Week High216.10
  • 52 Week High Date05/12/20
  • 52 Week Low57.86
  • 52 Week Low Date05/10/21

Key Stats

  • Market Cap5,013.81M
  • Shares Out65.51M
  • 10 Day Average Volume639,388.3
  • Dividend-
  • Dividend Yield-
  • Beta0.56
  • YTD % Change-22.51

KEY STATS

  • Open61.37
  • Day High62.89
  • Day Low61.10
  • Prev Close60.98
  • 52 Week High216.10
  • 52 Week High Date05/12/20
  • 52 Week Low57.86
  • 52 Week Low Date05/10/21
  • Market Cap5,013.81M
  • Shares Out65.51M
  • 10 Day Average Volume639,388.3
  • Dividend-
  • Dividend Yield-
  • Beta0.56
  • YTD % Change-22.51

RATIOS/PROFITABILITY

  • EPS (TTM)-4.21
  • P/E (TTM)-14.82
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company aims to develop a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. In...
Rajesh Parekh
Non-Executive Chairman
Bart Filius
President
Address
Generaal De Wittelaan 3
Malines (mechelen)
2800
Belgium